INS and Hyperglycemia: In T1DM models, adenoviral-induced hyperleptinemia corrected severe hyperglycemia, despite the absence of insulin, via suppressing glucagon action in the liver and enhancing the insulinomimetic action of the insulin-like growth factor in muscle [37].